tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EKF Diagnostics Tightens Capital Base with Treasury Share Buyback

Story Highlights
  • EKF Diagnostics repurchased 355,000 shares into treasury, trimming voting share capital.
  • Part of the buyback rebalances Christopher Mills’ indirect stake near the 30 percent level.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EKF Diagnostics Tightens Capital Base with Treasury Share Buyback

Claim 70% Off TipRanks This Holiday Season

EKF Diagnostics Holdings ( (GB:EKF) ) just unveiled an update.

EKF Diagnostics Holdings has repurchased 355,000 of its ordinary shares at a volume-weighted average price of 25.62 pence, with all shares to be held in treasury, reducing the number of shares in issue carrying voting rights to 434,793,112. As part of the buyback, the company acquired 105,000 shares from funds managed by Harwood, structured to keep non-executive director Christopher Mills’ aggregate indirect interest at around 30% of EKF’s voting rights, a move that fine-tunes the company’s capital structure while managing significant shareholder influence and regulatory thresholds for disclosure.

The most recent analyst rating on (GB:EKF) stock is a Hold with a £27.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.

Spark’s Take on GB:EKF Stock

According to Spark, TipRanks’ AI Analyst, GB:EKF is a Neutral.

EKF Diagnostics Holdings receives a score of 67, driven by strong financial performance and a positive earnings call. The company’s robust balance sheet and improved profitability are significant strengths. However, technical indicators suggest potential bearish momentum, and the valuation is moderate. The positive outlook from the earnings call, including strategic growth plans and a share buyback program, enhances the overall score.

To see Spark’s full report on GB:EKF stock, click here.

More about EKF Diagnostics Holdings

EKF Diagnostics Holdings is an AIM-listed global diagnostics company specialising in point-of-care analysers for hematology and diabetes, as well as life sciences services that include the specialist manufacture of enzymes and custom products for diagnostic, food and industrial applications. Headquartered in Penarth near Cardiff, EKF operates five manufacturing sites across the US and Germany and sells its products into more than 120 countries worldwide.

Average Trading Volume: 522,044

Technical Sentiment Signal: Strong Sell

Current Market Cap: £112.3M

Find detailed analytics on EKF stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1